Evidence map›Paper›PMID 33040278›Full record

ArticleJournal of clinical immunology2021

A Patient with Novel ICOS Mutation Presented with Progressive Loss of B Cells.

Asena Pınar Sefer, Louis Marie Charbonnier, Nurhan Kasap, Bengu Akcam, Yasemin Kendir Demirkol, Sevgi Bilgic Eltan, Ahmet Ozen, Elif Karakoc-Aydiner, Safa Baris

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Asena Pınar SeferSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey.
Louis Marie CharbonnierDivision of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Nurhan KasapSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey.
Bengu AkcamSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey.
Yasemin Kendir DemirkolUmraniye Education and Research Hospital, Department of Pediatric Genetics, Health Science University, Istanbul, Turkey.
Sevgi Bilgic EltanSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey.
Ahmet OzenSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey.
Elif Karakoc-AydinerSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey.
Safa BarisSchool of Medicine, Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Pendik, Istanbul, Turkey. safabaris@hotmail.com.ORCID 0000-0002-4730-9422

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMutationAdolescentBiomarkersB-LymphocytesDisease ManagementDNA Mutational AnalysisFemaleGenotypeHumansImmunoglobulins, IntravenousInducible T-Cell Co-Stimulator ProteinLymphocyte CountLymphopeniaPhenotypeBiomarkersICOS protein, humanImmunoglobulins, IntravenousInducible T-Cell Co-Stimulator Protein

Identifiers

PMID33040278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.